Generate Biomedicines
(NASDAQ) GENB
Generate Biomedicines Financials at a Glance
Market Cap
$1.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$16.04
Net Income (TTM)
-$106.03
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Price
$14.40
Volume
28,339
Open
$15.28
Price
$14.40
Volume
28,339
Open
$15.28
Previous Close
$14.40
Daily Range
$13.97 - $15.28
52-Week Range
$11.00 - $18.18
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Price
$14.40
Volume
28,339
Open
$15.28
Previous Close
$14.40
Daily Range
$13.97 - $15.28
52-Week Range
$11.00 - $18.18
Estimated Earnings Date
Aug 6, 2026
GENB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Generate Biomedicines
Industry
Biotechnology
Sector
Health CareEmployees
312
CEO
Michael T. Nally, MBA
Website
generatebiomedicines.comHeadquarters
Somerville, MA 02143, US
GENB Financials
Key Financial Metrics (TTM)
Gross Margin
100.00%
Operating Margin
-737.04%
Net Income Margin
-636.99%
Return on Equity
38.68%
Return on Capital
N/A
Return on Assets
-61.53%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
128.19M
Volume
28.34K
Avg. Volume
777.76K
Financials (TTM)
Gross Profit
$3.95M
Operating Income
-$64.11M
EBITDA
-$60.84M
Operating Cash Flow
-$80.39M
Capital Expenditure
-$3.78M
Free Cash Flow
-$84.17M
Cash & ST Invst.
$516.64M
Total Debt
$65.57M
Generate Biomedicines Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.22M
N/A
Gross Profit
$3.95M
N/A
Gross Margin
54.69%
N/A
Market Cap
$1.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$5.89M
N/A
Employees
312
N/A
Net Income
-$61.45M
N/A
EBITDA
-$60.84M
N/A
Quarterly Fundamentals
Total Cash
$516.64M
N/A
Total Debt
$65.57M
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$51.31M
N/A
Short Term Debt
$14.26M
N/A
Return on Assets
-61.53%
N/A
Return on Invested Capital
-94.79%
N/A
Free Cash Flow
-$84.17M
N/A
Operating Cash Flow
-$80.39M
N/A